Can Fite Biopharma Stock Price History

Below is the normalized historical share price chart for Can Fite Biopharma extending back to November 01, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Can Fite stands at 2.10, as last reported on the 28th of November, with the highest price reaching 2.25 and the lowest price hitting 2.07 during the day. If you're considering investing in Can Stock, it is important to understand the factors that can impact its price. Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of -0.002, which signifies that the company had a -0.002% return per unit of risk over the last 3 months. Can Fite Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Can Fite's Standard Deviation of 4.02, mean deviation of 2.78, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. At this time, Can Fite's Liabilities And Stockholders Equity is most likely to increase significantly in the upcoming years. The Can Fite's current Common Stock is estimated to increase to about 73.2 M, while Other Stockholder Equity is projected to decrease to roughly 106.5 M. . The Can Fite's current Price Earnings To Growth Ratio is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 12.14. Can Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.002

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns			CANF

Estimated Market Risk

Expected Return

Risk-Adjusted Return